References
- Bai S, Gupta V, Ahsan F. (2009). Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study. Eur J Pharm Sci 38:165–71
- Blumentals WA, Harris ST, Cole RE, et al. (2009). Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate. Ann Pharmacother 43:577–85
- Clark AR. (1995). The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm 115:69–78
- Dunford JE, Kwaasi AA, Rogers MJ, et al. (2008). Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. J Med Chem 51:2187–95
- Dunford JE, Thompson K, Coxon FP, et al. (2001). Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resportion in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296:235–42
- El-Ghany EA, Amine AM, EL-Sayed AS, et al. (2005). Radiochemical and biological characteristics of radioactive iodine labeled indomethacin for imaging of inflammation. J Radioanal Nucl Chem 266:117–24
- Ezra A, Golomb G. (2000). Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 42:175–95
- Gaspar MM, Gobbo O, Ehrhardt C. (2010). Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers. J Liposome Res 20:55–61
- Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:1
- Hathout RM, Woodman TJ, Mansour S, et al. (2010). Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci 40:188–96
- Jia HJ, Li W, Zhao K. (2006). Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector. Analytica Chimica Acta 562:171–5
- Lammers T, Kühnlein R, Kissel M, et al. (2005). Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. J Contr Rel 110:103–18
- Liu X-B, Ye J-X, Quan L-H, et al. (2008). Pulmonary delivery of scutellarin solution and mucoadhesive particles in rats. Eur J Pharm Biopharm 70:845–52
- Maddalena DJ. (1983). TISCON, a basic computer program for the calculation of the biodistribution of radionuclide-labelled drugs in rats and mice. Lucas Heights, Australia: Australian Atomic Energy Commission
- Mathai JC, Trsitram-Nagle S, Nagle JF, Zeidel ML. (2008). Structural determinants of water permeability through the lipid membrane. J Gen Physiol 131:69–76
- Miller PD. (2005). Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy. Clin Ther 27:361–76
- Milner RJ, Farese J, Henry CJ, et al. (2004). Bisphosphonates and cancer. J Vet Intern Med 18:597–604
- Nasr M, Awad GAS, Mansour S, et al. (2011). Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm 79:601–11
- Nasr M, Awad GAS, Mansour S, et al. (2013). Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium. Pharm Dev Technol 18:1078–88
- Nasr M, Mansour S, Mortada ND, Elshamy AA. (2008). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsulation 25:499–512
- Nasr M, Nawaz S, Elhissi A. (2012). Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. Int J Pharm 436:611–16
- Petrache HI, Tristram-Nagle S, Nagle JF. (1998). Fluid phase structure of EPC and DMPC bilayers. Chem Phys Lipids 95:83–94
- Presti FT, Chan SI. (1982). Cholesterol-phospholipid interaction in membranes. 1. Cholestane spin-label studies of the phase behavior of cholesterol-phospholipid liposomes. Biochemistry 21:3821–30
- Presti FT, Pace RJ, Chan SI. (1982). Cholesterol-phospholipid interaction in membranes. 2. Stoichiometry and molecular packing of cholesterol-rich domains. Biochemistry 21:3831–5
- Sakagami M. (2006). In vivo. in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 58:1030–60
- Vrignaud S, Hureaux J, Wack S, et al. (2012). Design, optimization and in vitro evaluation of reverse-micelle loaded lipid nanocarriers containing erlotinib hydrochloride. Int J Pharm 436:194–200